Tori Rodriguez, MA, LPC, AHC

To learn more about the escalating public health problems created by street drug xylazine, as well as treatment implications for clinicians, we interview hospital medicine specialist Varun Malayala, MD, MPH, FACP, FHM, and Edward C. Traver, MD.

Patients with hidradenitis suppurativa (HS) have a greater prevalence of rheumatoid arthritis (RA), spondyloarthritis (SpA), and psoriatic arthritis (PsA); we discuss these relationships with experts Louis Bridges, Jr., MD, PhD, and Saakshi Khattri, MD.

Experts discuss the challenges and potential resolutions for increasing diversity of clinical trial study populations.

We spoke with dermatologist Emily Gurnee, MD, about her experiences treating atopic dermatitis in children and educating their caretakers.

To learn more about the potential dermatologic effects of climate change and needed actions from clinicians, we interview expert Eva R. Parker, MD, FAAD.

We speak with Angela J. Lamb, MD, and Janiene Luke, MD, FAAD to learn more about the unique features of acne in patients with skin of color and how it is best treated.

The causes for, and ways to improve, the diagnostic delays in patients with psoriasis who progress to psoriatic arthritis are discussed.

Margareth Pierre-Louis, MD, MBA, FAAD discusses issues pertaining to skin cancer in people with skin of color as well as recommendations for the provision of multi-ethnic dermatology care.

Even though it is often thought of as a skin condition, many forms of epidermolysis bullosa are truly multisystem disorders, which makes coordinating the care complex.

Clinician competence in treating patients of various racial and ethnic backgrounds and the critical need for greater inclusion of diverse populations in trials investigating the pathophysiology and treatment of AD are underscored.

The pressing need to clarify risk factors and effective interventions for skin of color populations is underscored.

A roundtable discussion by experts in issues facing patients with skin of color reveals interesting insights.

Bioprinting for burns and other severe wounds could significantly accelerate wound closure and healing, reduce the risk for infection and minimize scarring.

The burden of pain as a component of atopic dermatitis treatment should be assessed and managed in a thorough manner.

The off-label use of treatments is especially prevalent in dermatology as the need for effective therapies outpaces the approval process. Experts discuss the most commonly employed treatments, the ethical implications of off-label use, and the need for patient education.

Katlein França, MD, PhD, spoke with Dermatology Advisor about the use of the behavior therapy technique “habit reversal training” (HRT) for the treatment of trichotillomania, excoriation disorder, and itch.

Atopic dermatitis, especially severe atopic dermatitis, is associated with allergic, autoimmune, and cardiovascular comorbidities.

There has been ongoing controversy regarding the relative safety of e-cigarettes vs combustible cigarettes.

Dermatology Advisor interviewed Raja Sivamani, MD, MS, AP, adjunct associate professor of clinical dermatology and director of clinical research at the University of California to discuss the application of ayurvedic medicine in dermatology.

Experts discuss their treatment strategies – and promising therapies – for treatment-resistant atopic dermatitis

With rapid advances in the use of machine learning in the past several years, there have been exciting developments in the field of dermatology.

Cupping involves creating suction on the skin using a glass, ceramic, bamboo, or plastic cup.

According to estimates from the National Institutes of Health, androgenic alopecia affects 30 million women and 50 million men in the United States.

Although these agents have shown considerable efficacy and an overall favorable safety profile, there have been numerous reports of adverse events affecting nearly every system in the body.

From scientific studies to niche-market magazines, supplements are in the spotlight.

Emerging evidence points to a potential link between H pylori infection and skin diseases including rosacea.

By the year 2050, the US Census Bureau estimates that 50% of the population will comprise people of color; yet, nearly 50% of dermatology residents and dermatologists have indicated that they received inadequate training on skin conditions in this population.

More research is needed to better understand the pathophysiologic mechanisms that result in increased risk for infection among individuals with psoriasis.

Detergents labeled as dye- and fragrance-free may be the best option for certain patients.

Itch is “learned” in the nervous system, said Dr Berger, with involvement by both central and peripheral neural processes.